Ishares 20 (TLT) 129.54 $TLT Extra Time to Take Stock of

New Post Public Reply Private Reply Replies (0) Message Board

Mar 26, 2016 at 12:27 AM

Ishares 20 (TLT) 129.54 $TLT

Extra Time to Take Stock of Indexes
at The Street - Thu Mar 24, 1:47PM CDT
Short-term view is more compelling on these 5.
USO: 10.06 (-0.05), SPY: 203.12 (-0.09), GLD: 116.33 (-0.28), IWM: 107.20 (+0.32), TLT: 129.54 (+0.05)

Filling March Madness in ETF Brackets
Sweta Killa - Zacks Investment Research - Thu Mar 24, 9:10AM CDT
Like the real championship, we have filled in the March Madness brackets into four factors, namely monetary policies, outperforming sectors, investment strategies, and fundamentals and the 16 related ETFs.
HYG: 81.35 (-0.36), VGK: 47.55 (-0.33), VIG: 80.20 (-0.11), XLU: 48.91 (+0.13), TLT: 129.54 (+0.05), UUP: 24.93 (+0.01), PWC: 70.68 (-0.21), IWD: 97.84 (-0.11), SPY: 203.12 (-0.09), QQQ: 107.26 (+0.03), GLD: 116.33 (-0.28), IWM: 107.20 (+0.32), XLE: 61.84 (+0.30)

How to Trade Growing 'Flight to Safety' Into Bonds, Gold as Oil, Euro Gain
at The Street - Mon Mar 21, 7:12AM CDT
The 'flight to safety' into U.S. Treasury bonds and gold continues as crude oil prices gain momentum and the dollar slumps.
JNK: 34.15 (-0.15), GLD: 116.33 (-0.28), UUP: 24.93 (+0.01), TLT: 129.54 (+0.05), GSG: 13.99 (-0.05)

Investing in the Era of Disintermediation
at The Street - Sat Mar 19, 11:00AM CDT
It's going to take a greater reliance on public financial policy to counteract the negative effects of declining consumer demand, so invest accordingly.
TLT: 129.54 (+0.05)

U.S. Treasury Yields Rise; Gold, Oil Set 2016 Highs: Check These Charts
at The Street - Mon Mar 14, 7:10AM CDT
The flight to safety into U.S. Treasury bonds is continuing, while gold and oil gain momentum. The dollar is weakening. These technical charts can help you decide how to react.
JNK: 34.15 (-0.15), GLD: 116.33 (-0.28), UUP: 24.93 (+0.01), TLT: 129.54 (+0.05), GSG: 13.99 (-0.05)

Beware Of The Dollar Deception
Macro Ops - at Seeking Alpha - Thu Mar 10, 1:10AM CST

USO: 10.06 (-0.05), SPY: 203.12 (-0.09), QQQ: 107.26 (+0.03), GLD: 116.33 (-0.28), DIA: 174.94 (+0.13), IWM: 107.20 (+0.32), TLT: 129.54 (+0.05)

Mosaic - Excellent Fundamentals In The Commodity Space
Individual Trader - at Seeking Alpha - Wed Mar 09, 11:31PM CST

SPY: 203.12 (-0.09), AXP: 60.47 (-0.16), IBM: 147.95 (+2.55), MOS: 27.26 (-0.76), SSRI: 5.46 (+0.13), WMT: 68.00 (+0.54), MCD: 123.29 (-0.90), GDX: 19.46 (+0.43), TLT: 129.54 (+0.05), SOIL: 8.78 (-0.05)

3 Pain Trades That Could Derail The Stock Market
Harry Long - at Seeking Alpha - Tue Mar 08, 6:41PM CST

USO: 10.06 (-0.05), GLD: 116.33 (-0.28), TLT: 129.54 (+0.05)

Where To Invest When Rates Go Negative
Wall Street Daily - Seeking Alpha - Tue Mar 08, 8:05AM CST
By Tim Maverick Negative interest rate policies (NIRP) are being adopted by central banks around the world. And it's quickly becoming the "new abnormal." The move to NIRP shows how desperate policy makers are becoming in their...
KO: 45.58 (+0.12), JNJ: 108.31 (-0.19), XOM: 83.98 (+0.23), MSFT: 54.21 (+0.24), DXJR: 25.86 (-0.19), TLT: 129.54 (+0.05), RINF: 27.48 (-0.01)

Trader's Notebook: Huge Winners Begin to Run Out of Gas
at The Street - Mon Mar 07, 8:00AM CST
Be prepared to either drop them or sit through volatility.
VALE: 4.04 (+0.20), SSRI: 5.46 (+0.13), AKS: 4.15 (+0.07), TLT: 129.54 (+0.05), X: 15.78 (+0.94)

How Will Treasuries, Gold, Oil Do This Week? Check the Charts
at The Street - Mon Mar 07, 7:38AM CST
Last week Treasuries stalled, gold gained momentum, oil went positive but the U.S. dollar remains choppy.
GLD: 116.33 (-0.28), UUP: 24.93 (+0.01), TLT: 129.54 (+0.05), GSG: 13.99 (-0.05)

Weekly ETF Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 04, 3:26PM CST

VXX: 19.30 (-0.11), UNG: 6.40 (+0.10), MUB: 111.07 (-0.14), FCG: 4.03 (+0.03), GAZ: 0.52 (+0.03), BRF: 11.95 (-0.14), ILF: 24.32 (-0.06), EWZ: 25.68 (+0.01), UUP: 24.93 (+0.01), TLT: 129.54 (+0.05)

Job headlines look good, but wages and hours worked fall
Seeking Alpha - at Seeking Alpha - Fri Mar 04, 7:37AM CST

TLT: 129.54 (+0.05), TBT: 37.47 (+0.03)

Progress Report On Climbing
Calafia Beach Pundit - Seeking Alpha - Fri Mar 04, 5:37AM CST
The main concern that markets are grappling with these days is the possibility that weakness in China and in the oil patch, coupled with escalating debt defaults could conspire to produce another recession in the U.S. I've argued that these fears are...
TIP: 113.12 (-0.26), USO: 10.06 (-0.05), SPY: 203.12 (-0.09), QQQ: 107.26 (+0.03), GLD: 116.33 (-0.28), DIA: 174.94 (+0.13), TLT: 129.54 (+0.05), RINF: 27.48 (-0.01)

The Seas Really Are Stormy
Comstock Partners - at Seeking Alpha - Fri Mar 04, 4:46AM CST
We have warned in the past about the potential for a world-wide deflationary bear market accompanied by a U.S., and possibly, global recession. We believe this recession and deflationary bear market have begun and expect it will last through most of...
SPY: 203.12 (-0.09), QQQ: 107.26 (+0.03), UST: 59.96 (-0.14), GLD: 116.33 (-0.28), DIA: 174.94 (+0.13), TLT: 129.54 (+0.05), RINF: 27.48 (-0.01)

Bear Hunt Rally Ends Soon
Kevin Cook - Zacks Investment Research - Thu Mar 03, 4:26PM CST
Why, and where, the relief rally will end very soon
SPY: 203.12 (-0.09), QQQ: 107.26 (+0.03), VXX: 19.30 (-0.11), IWM: 107.20 (+0.32), TLT: 129.54 (+0.05)

Using CoT Data To Examine Current Trader Positioning In U.S. Stocks And Crude Oil
Free CoT Data - at Seeking Alpha - Thu Mar 03, 7:38AM CST

WEAT: 8.86 (-0.01), USO: 10.06 (-0.05), SPY: 203.12 (-0.09), UNG: 6.40 (+0.10), FXB: 138.42 (+0.34), CORN: 21.26 (+0.06), TLT: 129.54 (+0.05)

Buying Bonds Now Is Both Good And Bad
Michael A. Gayed, CFA - Seeking Alpha - Wed Mar 02, 2:10PM CST
"I'm an accumulation of every single thing I've done, good and bad." - David Millar Bonds historically have tended to be a core part of pretty much any and every portfolio, and for good reason. So long as you have a diversified basket of fixed...
JNK: 34.15 (-0.15), TLT: 129.54 (+0.05)

Which Way Wednesday - Russell 1,050 Or Doom Again
Philip Davis - at Seeking Alpha - Wed Mar 02, 12:19PM CST
Here we are again . Back on Jan 11th , we pegged 1,050 on the Russell as the most critical line in the markets and failing that turned us bearish and turning bearish made us a ton of money last month. That was also a Beige Book week and we were...
SQQQ: 19.51 (-0.03), TLT: 129.54 (+0.05), AAPL: 105.67 (-0.46)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...